S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:TMDI

Titan Medical Stock Forecast, Price & News

$1.80
-0.19 (-9.55 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.65
Now: $1.80
$1.98
50-Day Range
$1.79
MA: $2.57
$3.23
52-Week Range
$0.12
Now: $1.80
$3.47
Volume3.30 million shs
Average Volume4.55 million shs
Market Capitalization$193.80 million
P/E Ratio180.00
Dividend YieldN/A
Beta3.53
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Titan Medical logo

Headlines

Titan Medical bags two new patents in U.S.
September 17, 2020 |  seekingalpha.com
Titan Medical CFO retires, new chief appointed
September 8, 2020 |  seekingalpha.com
Titan Medical Issues Shareholder Update Letter
July 14, 2020 |  finance.yahoo.com
Titan Medical Inc. - Ordinary Shares
July 3, 2020 |  www.benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMDI
CUSIPN/A
CIKN/A
Phone416-548-7522
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.29) per share

Profitability

Net Income$-41,910,000.00

Miscellaneous

Market Cap$193.80 million
Next Earnings Date5/12/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.68 out of 5 stars

Medical Sector

1254th out of 1,969 stocks

Surgical & Medical Instruments Industry

115th out of 169 stocks

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.80
-0.19 (-9.55 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMDI News and Ratings via Email

Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Titan Medical (NASDAQ:TMDI) Frequently Asked Questions

Is Titan Medical a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Titan Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TMDI, but not buy additional shares or sell existing shares.
View analyst ratings for Titan Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Titan Medical?

Wall Street analysts have given Titan Medical a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Titan Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Titan Medical?

Titan Medical saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 2,520,000 shares, an increase of 137.7% from the January 28th total of 1,060,000 shares. Based on an average daily volume of 3,490,000 shares, the short-interest ratio is currently 0.7 days. Approximately 2.5% of the company's shares are short sold.
View Titan Medical's Short Interest
.

When is Titan Medical's next earnings date?

Titan Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for Titan Medical
.

How has Titan Medical's stock been impacted by COVID-19 (Coronavirus)?

Titan Medical's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TMDI stock has increased by 800.0% and is now trading at $1.80.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TMDI?

1 Wall Street analysts have issued twelve-month price targets for Titan Medical's shares. Their forecasts range from $1.00 to $1.00. On average, they expect Titan Medical's share price to reach $1.00 in the next year. This suggests that the stock has a possible downside of 44.4%.
View analysts' price targets for Titan Medical
or view top-rated stocks among Wall Street analysts.

Who are Titan Medical's key executives?

Titan Medical's management team includes the following people:
  • Mr. David J. McNally, Pres, CEO & Chairman (Age 59, Pay $495k)
  • Mr. Sachin A. Sankholkar, VP of Marketing
  • Dr. Bruce Giles Wolff, Sr. Advisor & Member of Surgeon Advisory Board
  • Dr. Perry A. Genova, Sr. VP of R&D
  • Ms. Monique L. Delorme CPA, CA, Chief Financial Officer
  • Mr. Jasminder Brar, VP of Legal, IP & Strategic Initiatives, Corp. Sec. and Gen. Counsel

Who are some of Titan Medical's key competitors?

What other stocks do shareholders of Titan Medical own?

What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

Who are Titan Medical's major shareholders?

Titan Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.65%), Armistice Capital LLC (0.26%), JPMorgan Chase & Co. (0.07%), Stratos Wealth Partners LTD. (0.06%), Jane Street Group LLC (0.03%) and Private Wealth Advisors Inc. (0.02%).

Which major investors are buying Titan Medical stock?

TMDI stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Armistice Capital LLC, Jane Street Group LLC, JPMorgan Chase & Co., Stratos Wealth Partners LTD., and Private Wealth Advisors Inc..

How do I buy shares of Titan Medical?

Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $1.80.

How much money does Titan Medical make?

Titan Medical has a market capitalization of $193.80 million.

How many employees does Titan Medical have?

Titan Medical employs 9 workers across the globe.

What is Titan Medical's official website?

The official website for Titan Medical is www.titanmedicalinc.com.

Where are Titan Medical's headquarters?

Titan Medical is headquartered at 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7.

How can I contact Titan Medical?

Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company can be reached via phone at 416-548-7522.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.